A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.

Publication Type:

Journal Article

Source:

Breast cancer research and treatment, Volume 85, Issue 2, p.143-50 (2004)

Keywords:

Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Cyclophosphamide, Doxorubicin, Female, Humans, Infusions, Intravenous, Middle Aged, Neoplasm Metastasis, Treatment Outcome

Abstract:

To evaluate whether the high complete response (CR) rates for the combination of doxorubicin and paclitaxel in metastatic breast cancer observed in two European studies could be replicated in a multi-institutional cooperative group trial.